Detalhe da pesquisa
1.
Delivery of oncolytic vaccinia virus by matched allogeneic stem cells overcomes critical innate and adaptive immune barriers.
J Transl Med
; 17(1): 100, 2019 03 27.
Artigo
em Inglês
| MEDLINE | ID: mdl-30917829
2.
First-in-human study of TK-positive oncolytic vaccinia virus delivered by adipose stromal vascular fraction cells.
J Transl Med
; 17(1): 271, 2019 08 19.
Artigo
em Inglês
| MEDLINE | ID: mdl-31426803
3.
Correction to: Delivery of oncolytic vaccinia virus by matched allogeneic stem cells overcomes critical innate and adaptive immune barriers.
J Transl Med
; 19(1): 414, 2021 Oct 04.
Artigo
em Inglês
| MEDLINE | ID: mdl-34607595
4.
Canine Adipose-Derived Mesenchymal Stem Cells (cAdMSCs) as a "Trojan Horse" in Vaccinia Virus Mediated Oncolytic Therapy against Canine Soft Tissue Sarcomas.
Viruses
; 12(7)2020 07 12.
Artigo
em Inglês
| MEDLINE | ID: mdl-32664672